Targeted biologic inhibition of both tumor cell-intrinsic and intercellular CLPTM1L/CRR9-mediated chemotherapeutic drug resistance
D Parashar, A Geethadevi, D McAllister… - NPJ Precision …, 2021 - nature.com
Recurrence of therapy-resistant tumors is a principal problem in solid tumor oncology,
particularly in ovarian cancer. Despite common complete responses to first line, platinum …
particularly in ovarian cancer. Despite common complete responses to first line, platinum …
Sperm protein 17 targeting for epithelial ovarian cancer treatment in the era of modern immunoengineering
M Poplawska, D Dutta, Y Lee, SH Lim - Molecular Therapy-Oncolytics, 2021 - cell.com
Due to the vague symptomatology of the disease and a lack of effective screening methods,
most patients with epithelial ovarian cancer (EOC) present late in their disease. Despite …
most patients with epithelial ovarian cancer (EOC) present late in their disease. Despite …